| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/20/2006 | US20060159767 Nanoparticulate bicalutamide formulations |
| 07/20/2006 | US20060159766 Nanoparticulate tacrolimus formulations |
| 07/20/2006 | US20060159763 Osmotic device containing amantadine and an osmotic salt |
| 07/20/2006 | US20060159762 Stable pharmaceutical composition comprising an active substance in the form of solid solution |
| 07/20/2006 | US20060159761 for therapy of allergic and/or inflammatory conditions of the skin and airway passages; desloratadine-pseudoephedrine once-a-day product which produces a release rate profile for pseudoephedrine over an extended period in excess of twelve hours while maintaining delivery of desloratadine |
| 07/20/2006 | US20060159760 Drug composition having active ingredient adhered at high concentration to spherical core |
| 07/20/2006 | US20060159759 Tablet containing water-absorbing amino acid |
| 07/20/2006 | US20060159758 Coating composition for taste masking coating and methods for their application and use |
| 07/20/2006 | US20060159757 Pharmaceutical composition for controlled release of beta-lactam antibiotics in combination with beta-lactamase inhibitors |
| 07/20/2006 | US20060159756 Method to obtain microparticles containing an H+,K+-ATP-ASE inhibitor |
| 07/20/2006 | US20060159754 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 07/20/2006 | US20060159752 Extended release matrix tablets |
| 07/20/2006 | US20060159751 Controlled release pharmaceutical compositions of carbidopa and levodopa |
| 07/20/2006 | US20060159750 Pharmaceutical dosage form bearing pregnancy-friendly indicia |
| 07/20/2006 | US20060159749 Mesalamine inglobated in a three-component matrix structure, i.e. a structure formed by successive amphiphilic, lipophilic or inert matrices and finally inglobated or dispersed in hydrophilic matrices |
| 07/20/2006 | US20060159748 Oral immediate release formulation of a poorly water-soluble active substance |
| 07/20/2006 | US20060159747 Telmisartan and hydrochlorothiazide combination therapy |
| 07/20/2006 | US20060159746 Compositions comprising fatty acids and amino acids |
| 07/20/2006 | US20060159744 Timed dual release dosage forms comprising a short acting hypnotic or a salt thereof |
| 07/20/2006 | US20060159743 Administering once daily; improving patient compliance |
| 07/20/2006 | US20060159742 Stabilized individually coated ramipril particles, compositions and methods |
| 07/20/2006 | US20060159741 Pharmaceutical compositions comprising amoxicillin and clavulanic acid |
| 07/20/2006 | US20060159740 Hydrophobic photosensitizer formulations for photodynamic therapy |
| 07/20/2006 | US20060159736 Liposome formulations of boronic acid compounds |
| 07/20/2006 | US20060159735 Method of reclaiming drug compound from liposomal drug manufacturing stream |
| 07/20/2006 | US20060159733 Method of providing hemostasis to a wound |
| 07/20/2006 | US20060159728 Method of feeding milk replacer with carnitine |
| 07/20/2006 | US20060159727 Prevention of Systemic Microbial Infection |
| 07/20/2006 | US20060159726 Method and compositions for potentiating pharmaceuticals with amino acid based medical foods |
| 07/20/2006 | US20060159724 Nutritional supplement for the management of weight |
| 07/20/2006 | US20060159720 Bioresorbable sealants for porous vascular grafts |
| 07/20/2006 | US20060159714 Use of an antioxidant in a dermatological and/or cosmetic composition |
| 07/20/2006 | US20060159713 Bendamustine pharmaceutical compositions |
| 07/20/2006 | US20060159712 Lipid particles comprising bioactive agents, methods of preparing and uses thereof |
| 07/20/2006 | US20060159711 Therapeutic agent for hemorrhoidal disease |
| 07/20/2006 | US20060159706 Novel insertion sites in pox vectors |
| 07/20/2006 | US20060159699 Dengue viruses useful for vaccination against Flavivirus; Modified Vaccinia Virus Ankara (MVA); stable, can easily be produced |
| 07/20/2006 | US20060159698 Drug product for intestinal disease |
| 07/20/2006 | US20060159679 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 07/20/2006 | US20060159672 Identification of self and non-self antigens implicated in autoimmune diseases |
| 07/20/2006 | US20060159665 Seed tear resistant scaffold |
| 07/20/2006 | US20060159656 Formulations for IL-11 |
| 07/20/2006 | US20060159655 Treating immunological disorders using agonists of interleukin-21 / interleukin-21 receptor |
| 07/20/2006 | US20060159651 Gradient molecular weight viscoelastic solutions |
| 07/20/2006 | US20060159650 Composition and method for covalently coupling an antithrombotic substance and a hydrophilic polymer |
| 07/20/2006 | US20060159646 Hair regenerator |
| 07/20/2006 | US20060159638 O/W emulsions comprising micronized biologically active agents |
| 07/20/2006 | US20060159632 Drug formulation for mouth or pharynx comprising local anesthetic |
| 07/20/2006 | US20060159629 Perforated; standard particle size; nonaggregating; flowability, dispersibility; lower dosage inhalants |
| 07/20/2006 | US20060159628 Nanoparticulate benzothiophene formulations |
| 07/20/2006 | US20060159624 Transmucosal absorption through oral mucosa to systemic circulatory system; bioavailability, rapid onset; active ingredient, solvent and low molecular weight hydrocarbon propellant; sleep disorders |
| 07/20/2006 | US20060159618 Preparation of compounds useful for the detection of hypoxia |
| 07/20/2006 | US20060158725 Laser projector |
| 07/20/2006 | DE19507822B4 Substituierte DTPA-Monoamide der zentralen Carbonsäure und deren Metallkomplexe, diese Komplexe enthaltende pharmazeutische Mittel, deren Verwendung in der Diagnostik und Therapie sowie Verfahren zur Herstellung der Komplexe und Mittel Substituted DTPA-monoamides of central carboxylic acid and their metal complexes, pharmaceutical agents containing these complexes, their use in diagnostics and therapy and methods for preparing the complexes and agents |
| 07/20/2006 | DE10227938B4 Pharmazeutische Zubereitung, Verfahren zu ihrer Herstellung sowie deren Verwendung A pharmaceutical preparation, processes for their preparation and their use |
| 07/20/2006 | DE102005003788A1 siRNA-Moleküle zur Behandlung von Blutgefäßen siRNA molecules for the treatment of blood vessels |
| 07/20/2006 | DE102005001645A1 Topisches Produkt zur Vorbeugung und Behandlung von Windeldermatitis A topical product for the prevention and treatment of diaper rash |
| 07/20/2006 | DE102005001479A1 Mittel, enthaltend Folsäure, Vitamin B6 und Vitamin B12, und dessen Verwendung Compositions comprising folic acid, vitamin B6 and vitamin B12, and its use |
| 07/20/2006 | DE102005001297A1 Aerosolformulierung für die Inhalation enthaltend ein Anticholinergikum Aerosol formulation for inhalation containing an anticholinergic |
| 07/20/2006 | DE102005001113A1 Verwendung von Metallkomplexen von Tetrapyrrollheterocyclen zur Behandlung von entzündlichen Magen/Darmerkrankungen Use of metal complexes of Tetrapyrrollheterocyclen for treating inflammatory gastric / intestinal diseases |
| 07/20/2006 | DE102005001053A1 Quadratsäurederivate Squaric acid derivatives |
| 07/20/2006 | DE102005000719A1 Pharmazeutische Zusammensetzung zur kontrollierten Freisetzung von ß-Lactam-Antibiotika in Kombination mit ß-Lactamase-Inhibitoren A pharmaceutical composition for controlled release of beta-lactam antibiotics in combination with beta-lactamase inhibitors |
| 07/20/2006 | DE102004063755A1 Verwendung von CGRP-Antagonisten zur Behandlung und Vorbeugung von Hitzewallungen bei Patienten mit Prostatakrebs Use of CGRP antagonists for the treatment and prevention of hot flushes in patients with prostate cancer |
| 07/20/2006 | DE10134445B4 Bis-acylharnstoffe, deren Derivate sowie deren Verwendung Up-acylureas, their derivatives and their use |
| 07/20/2006 | CA2637141A1 Kits and improved compositions for treating lower urinary tract |
| 07/20/2006 | CA2601343A1 Substituted aminomethylene sulphonamides, production and use thereof as medicaments |
| 07/20/2006 | CA2595159A1 Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders |
| 07/20/2006 | CA2595126A1 Methods and compositions for preventing and treating a disease related to glycan dysregulation |
| 07/20/2006 | CA2595075A1 Pyrrolodihydroisoquinolines as antiproliferative agents |
| 07/20/2006 | CA2594869A1 Method for preparation of 10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide |
| 07/20/2006 | CA2594821A1 Process for preparing lansoprazole |
| 07/20/2006 | CA2594775A1 Agents containing folic acid, vitamin b6 and vitamin b12, and the use thereof |
| 07/20/2006 | CA2594770A1 5-pyrrolidinylsulfonyl isatin derivatives |
| 07/20/2006 | CA2594709A1 Intravenous formulations of pde-5 inhibitors |
| 07/20/2006 | CA2594675A1 Therapeutic agent for chronic obstructive pulmonary disease (copd), cystic fibrosis or pulmonary hypertension |
| 07/20/2006 | CA2594654A1 N-((2z)-2-((4-hydroxyphenyl)imino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2 |
| 07/20/2006 | CA2594569A1 Synthesis of sodium narcistatin and related compounds |
| 07/20/2006 | CA2594484A1 Cinnamate salts of a beta-2 adrenergic agonist |
| 07/20/2006 | CA2594460A1 A method of modulating t cell functioning |
| 07/20/2006 | CA2594449A1 1,3-diaryl substituted ureas as modulators of kinase activity |
| 07/20/2006 | CA2594425A1 5-membered annelated heterocyclic pyrimidines as kinase inhibitors |
| 07/20/2006 | CA2594422A1 Pyrazolopyrimidines as cell cycle kinase inhibitors |
| 07/20/2006 | CA2594419A1 Substituted 4-phenyltetrahydroisoquinolines, methods for producing them, their use as drug, and drug containing them |
| 07/20/2006 | CA2594411A1 Peptidic biaryl antibacterial compounds comprising one or more basic amino acids |
| 07/20/2006 | CA2594389A1 6-phenylhex-5-enoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic uses thereof |
| 07/20/2006 | CA2594377A1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 07/20/2006 | CA2594340A1 Aminophenyl derivatives as selective androgen receptor modulators |
| 07/20/2006 | CA2594101A1 Substance mixture |
| 07/20/2006 | CA2594013A1 Methods and compositions related to modulating the extracellular stem cell environment |
| 07/20/2006 | CA2593780A1 The use of alpha-ketoglutarate in the treatment or prophylaxis of neoplastic disease |
| 07/20/2006 | CA2593661A1 Substituted cyclopentanes or cyclopentanones for the treatment of ocular hypertensive conditions |
| 07/20/2006 | CA2593582A1 Bendamustine pharmaceutical compositions |
| 07/20/2006 | CA2593537A1 Methods and pharmaceutical compositions useful for treating psoriasis |
| 07/20/2006 | CA2593515A1 Amino-imidazolones for the inhibition of beta-secretase |
| 07/20/2006 | CA2593482A1 Heteroaryl substituted quinolin-4-ylamine analogues |
| 07/20/2006 | CA2593464A1 Genes involved in the regulation of angiogenesis, pharmaceutical preparations containing them and uses thereof |
| 07/20/2006 | CA2593450A1 Indole derivatives for treating viral infections |
| 07/20/2006 | CA2593439A1 Thiazole-4-carboxamide derivatives as mglur5 antagonists |
| 07/20/2006 | CA2593398A1 Purine derivatives acting as a2a receptor agonists |
| 07/20/2006 | CA2593321A1 Apoptosis-inducing antineoplastic silver (i) coordination complexes |